These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1732548)

  • 21. Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides.
    Youssefyeh RD; Campbell HF; Klein S; Airey JE; Darkes P; Powers M; Schnapper M; Neuenschwander K; Fitzpatrick LR; Pendley CE
    J Med Chem; 1992 Mar; 35(5):895-903. PubMed ID: 1312602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors.
    Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S
    Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model.
    Langlois A; Pascaud X; Junien JL; Dahl SG; Rivière PJ
    Eur J Pharmacol; 1996 Dec; 318(1):141-4. PubMed ID: 9007525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
    Waikar MV; Hegde SS; Ford AP; Clarke DE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of 2,3-dihydrobenzofuran-7-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
    Kuroita T; Yasumoto M; Inaba K; Sakamori M; Takehara S; Kawakita T
    Chem Pharm Bull (Tokyo); 1994 Jan; 42(1):95-100. PubMed ID: 8124772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae.
    Yang DC; Goldstin B; Moormann AE; Flynn DL; Gullikson GW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1339-47. PubMed ID: 8396633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagus.
    Baxter GS; Clarke DE
    Eur J Pharmacol; 1992 Mar; 212(2-3):225-9. PubMed ID: 1601064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DAU 6285: a novel antagonist at the putative 5-HT4 receptor.
    Schiavone A; Giraldo E; Giudici L; Turconi M; Sagrada A
    Life Sci; 1992; 51(8):583-92. PubMed ID: 1640809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus.
    Chaput Y; Araneda RC; Andrade R
    Eur J Pharmacol; 1990 Jul; 182(3):441-56. PubMed ID: 2226619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons.
    Rasmussen K; Stockton ME; Czachura JF
    Eur J Pharmacol; 1991 Nov; 205(1):113-6. PubMed ID: 1811993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constipation evoked by 5-HT3-receptor antagonism: evidence for heterogeneous efficacy among different antagonists in guinea-pigs.
    Sanger GJ; Wardle KA
    J Pharm Pharmacol; 1994 Aug; 46(8):666-70. PubMed ID: 7815281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine.
    Chappell AS; Bay JM; Botzum GD; Cohen ML
    Neuropharmacology; 1994; 33(3-4):509-13. PubMed ID: 7984290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro.
    Contesse V; Hamel C; Delarue C; Lefebvre H; Vaudry H
    Eur J Pharmacol; 1994 Nov; 265(1-2):27-33. PubMed ID: 7883026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New 5-HT3 (serotonin-3) receptor antagonists. I. Synthesis and structure-activity relationships of pyrido[1,2-a]indoles.
    Kato M; Ito K; Nishino S; Yamakuni H; Takasugi H
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2546-55. PubMed ID: 7697771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disposition of zatosetron, a serotonin (5-HT3) receptor antagonist, in humans.
    Franz PM; Mattiuz EL; Hatcher BL; DeSante KA; Breau AP; Occolowitz JL; Dorman DE; Schmid CR; Goldberg MJ; Rubin A
    Drug Metab Dispos; 1993; 21(2):249-54. PubMed ID: 8097693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntheses of monocyclic and bicyclic 2,4(1H,3H)-pyrimidinediones and their serotonin 2 antagonist activities.
    Watanabe Y; Usui H; Shibano T; Tanaka T; Kanao M
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2726-32. PubMed ID: 2076558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects on general behaviour and neurotransmitter functions of a new 5-hydroxytryptamine3 receptor antagonist with potential therapeutic relevance in central nervous system disturbances.
    Rizzi CA; Prudentino A; Giraldo E
    Arzneimittelforschung; 1993 Oct; 43(10):1033-41. PubMed ID: 7903536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged anti-emetic activity and 5-HT3-receptor antagonism by BRL 46470 in conscious ferrets.
    Bermudez J; Sanger GJ
    J Pharm Pharmacol; 1994 Jun; 46(6):520-1. PubMed ID: 7932054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.